Document is current
Any future updates will be listed below
-
Authors
Tang, Lin
Hu, Weijun
Li, Yajun
Guo, Chunyan
Feng, Zhaojie
Bai, Ningpei
Wang, Ruize
Zhang, Shaobai
Wang, Yuelei
Liu, Siyu
Wang, Xiaoqi
Liu, Qianqian
Liu, Xiaoxue
Rodewald, Lance E.
Wang, Fuzhen
Yin, Zundong
-
Funding
Funding for this research was provided by:
This work was supported by the Emergency Key Program of Guangzhou Laboratory, project Evaluation of Effectiveness of COVID-19 Vaccine against SARS-CoV-2 Outbreak in China. (SRPG22–009)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 18 November 2025
First Online: 5 December 2025
Declarations
:
: This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association.The study protocol, the written informed consent form, and individual-identifying data items were approved by the Ethics Review Board of the Chinese Center for Disease Control and Prevention (Approval Notice No. 202405). All participants provided informed consent for sample storage and potential future research.
: Not applicable.
: The authors declare no competing interests.
